Daniel Weghuber

5.7k total citations · 1 hit paper
129 papers, 3.4k citations indexed

About

Daniel Weghuber is a scholar working on Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Daniel Weghuber has authored 129 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Endocrinology, Diabetes and Metabolism, 39 papers in Public Health, Environmental and Occupational Health and 32 papers in Epidemiology. Recurrent topics in Daniel Weghuber's work include Obesity, Physical Activity, Diet (33 papers), Liver Disease Diagnosis and Treatment (17 papers) and Diabetes Treatment and Management (15 papers). Daniel Weghuber is often cited by papers focused on Obesity, Physical Activity, Diet (33 papers), Liver Disease Diagnosis and Treatment (17 papers) and Diabetes Treatment and Management (15 papers). Daniel Weghuber collaborates with scholars based in Austria, Germany and Sweden. Daniel Weghuber's co-authors include Harald Mangge, David Thivel, W. Schnedl, Margarita Barrientos‐Pérez, Kurt Widhalm, Sieglinde Zelzer, Katharina Paulmichl, Timothy Barrett, Teodor T. Postolache and Dietmar Fuchs and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Daniel Weghuber

121 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Once-Weekly Semaglutide in Adolescents with Obesity

2022 338 citations Daniel Weghuber, Timothy Barrett et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Weghuber Austria	32	901	890	885	721	538	129	3.4k
Thomas M. Barber United Kingdom	33	1.1k 1.2×	1.2k 1.3×	1.2k 1.3×	504 0.7×	872 1.6×	127	4.5k
Gemma Rojo‐Martínez Spain	37	1.2k 1.3×	628 0.7×	910 1.0×	699 1.0×	714 1.3×	158	3.9k
Susanna Wiegand Germany	33	1.0k 1.1×	1.2k 1.4×	731 0.8×	490 0.7×	596 1.1×	163	3.8k
Rachael E. Van Pelt United States	34	1.3k 1.4×	621 0.7×	1.6k 1.8×	804 1.1×	563 1.0×	59	4.1k
Sakineh Shab‐Bidar Iran	38	585 0.6×	1.4k 1.5×	1.5k 1.7×	535 0.7×	562 1.0×	249	4.8k
Shaun Sabico Saudi Arabia	41	682 0.8×	893 1.0×	1.6k 1.8×	877 1.2×	902 1.7×	188	4.9k
Liisa Byberg Sweden	38	706 0.8×	1.3k 1.4×	1.2k 1.3×	435 0.6×	550 1.0×	119	4.7k
Nancy G. Sebring United States	34	699 0.8×	1.4k 1.5×	1.5k 1.7×	533 0.7×	621 1.2×	48	4.5k
Susann Blüher Germany	32	591 0.7×	1.3k 1.4×	1.5k 1.7×	1.3k 1.8×	440 0.8×	90	4.3k
S. John Weisnagel Canada	30	993 1.1×	645 0.7×	1.4k 1.6×	598 0.8×	725 1.3×	92	3.9k

Countries citing papers authored by Daniel Weghuber

Since Specialization

Citations

This map shows the geographic impact of Daniel Weghuber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Weghuber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Weghuber more than expected).

Fields of papers citing papers by Daniel Weghuber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Weghuber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Weghuber. The network helps show where Daniel Weghuber may publish in the future.

Co-authorship network of co-authors of Daniel Weghuber

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Weghuber. A scholar is included among the top collaborators of Daniel Weghuber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Weghuber. Daniel Weghuber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huber, Sara, Daniel Weghuber, Thorsten Fischer, et al.. (2025). Mitochondrial Oxidative Phosphorylation Alterations in Placental Tissues from Early- and Late-Onset Preeclampsia. International Journal of Molecular Sciences. 26(9). 3951–3951.

Wiemann, Dagobert, Alexander J. Eckert, Svenja Meyhöfer, et al.. (2024). Poorly controlled pediatric type 1 diabetes mellitus is a risk factor for metabolic dysfunction associated steatotic liver disease (MASLD): An observational study. Journal of Pediatric Gastroenterology and Nutrition. 78(5). 1027–1037. 3 indexed citations

Torbahn, Gabriel, Tamara Brown, Louisa Ells, et al.. (2024). Anti‐Obesity Medication in the Management of Children and Adolescents With Obesity: Recent Developments and Research Gaps. Clinical Endocrinology. 102(1). 51–61. 4 indexed citations

Baker, Jennifer L., Carine de Beaufort, Ruth M. Belin, et al.. (2024). Considerations for the design and conduct of pediatric obesity pharmacotherapy clinical trials: Proceedings of expert roundtable meetings. Pediatric Obesity. 19(11). e13161–e13161. 2 indexed citations

Aydın, Banu Küçükemre, Hannes Manell, Hjalti Kristinsson, et al.. (2023). Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control. Frontiers in Endocrinology. 14. 1293093–1293093. 4 indexed citations

Manell, Hannes, Qiujin Shen, Kirsten Roomp, et al.. (2023). Biomarker screening in children and adolescents reveals that CUB domain-containing protein 1 is associated with obesity and that hepatocyte growth factor is associated with weight gain. Obesity Medicine. 39. 100481–100481. 2 indexed citations

Kelly, Aaron S., Silva Arslanian, Dan Hesse, et al.. (2023). Reducing BMI below the obesity threshold in adolescents treated with once‐weekly subcutaneous semaglutide 2.4 mg. Obesity. 31(8). 2139–2149. 24 indexed citations

Stein, Robert, Johannes Riedel, Marco Colombo, et al.. (2023). Single Point Insulin Sensitivity Estimator (SPISE) As a Prognostic Marker for Emerging Dysglycemia in Children with Overweight or Obesity. Metabolites. 13(1). 100–100. 4 indexed citations

Prinz, Nicole, Hugo Pomares‐Millan, Almut Dannemann, et al.. (2023). Who benefits most from outpatient lifestyle intervention? An IMI‐SOPHIA study on pediatric individuals living with overweight and obesity. Obesity. 31(9). 2375–2385. 2 indexed citations

10.

Weghuber, Daniel, René G. Feichtinger, Sara Huber, et al.. (2022). Hydrogen Sulfide Metabolizing Enzymes in the Intestinal Mucosa in Pediatric and Adult Inflammatory Bowel Disease. Antioxidants. 11(11). 2235–2235. 13 indexed citations

11.

Schneider, Anna-Maria, Franz Zimmermann, Susanne M. Brunner, et al.. (2022). Expression of Oxidative Phosphorylation Complexes and Mitochondrial Mass in Pediatric and Adult Inflammatory Bowel Disease. Oxidative Medicine and Cellular Longevity. 2022(1). 9151169–9151169. 9 indexed citations

12.

Blüher, Susann, Susanna Wiegand, Nicole Prinz, et al.. (2022). Uric acid and gamma‐glutamyl‐transferase in children and adolescents with obesity: Association to anthropometric measures and cardiometabolic risk markers depending on pubertal stage, sex, degree of weight loss and type of patient care: Evaluation of the adiposity patient follow‐up registry. Pediatric Obesity. 18(3). e12989–e12989. 8 indexed citations

13.

Julian, Valérie, Iris Ciba, Roger Olsson, et al.. (2021). Association between Metabolic Syndrome Diagnosis and the Physical Activity—Sedentary Profile of Adolescents with Obesity: A Complementary Analysis of the Beta-JUDO Study. Nutrients. 14(1). 60–60. 11 indexed citations

14.

Wortmann, Saskia B., Brigitte Meunier, Lamia Mestek, et al.. (2020). Bi-allelic Variants in TKFC Encoding Triokinase/FMN Cyclase Are Associated with Cataracts and Multisystem Disease. The American Journal of Human Genetics. 106(2). 256–263. 18 indexed citations

15.

Schneider, Anna-Maria, Franz Zimmermann, René G. Feichtinger, et al.. (2020). Age-Related Deterioration of Mitochondrial Function in the Intestine. Oxidative Medicine and Cellular Longevity. 2020. 1–12. 15 indexed citations

16.

Dereń, Katarzyna, Daniel Weghuber, Margherita Caroli, et al.. (2019). Consumption of Sugar-Sweetened Beverages in Paediatric Age: A Position Paper of the European Academy of Paediatrics and the European Childhood Obesity Group. Annals of Nutrition and Metabolism. 74(4). 296–302. 52 indexed citations

17.

Manell, Hannes, Robin Strand, Anders Forslund, et al.. (2019). Brown adipose tissue estimated with the magnetic resonance imaging fat fraction is associated with glucose metabolism in adolescents. Pediatric Obesity. 14(9). e12531–e12531. 11 indexed citations

18.

Tamborlane, William V., Margarita Barrientos‐Pérez, Udi Fainberg, et al.. (2019). Liraglutide in Children and Adolescents with Type 2 Diabetes. New England Journal of Medicine. 381(7). 637–646. 222 indexed citations

19.

Thivel, David, Susanne Ring‐Dimitriou, Daniel Weghuber, M.-L. Frelut, & Grace O’Malley. (2016). Muscle Strength and Fitness in Pediatric Obesity: a Systematic Review from the European Childhood Obesity Group. Obesity Facts. 9(1). 52–63. 142 indexed citations

20.

Weghuber, Daniel, Michael Roden, Marek Chmelík, et al.. (2010). Vascular function in obese children with non-alcoholic fatty liver disease. International Journal of Pediatric Obesity. 6(2). 120–127. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact